Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P39
Within normal range
vs 2Y Ago
-1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -9.95% |
| Q2 2025 | 32.32% |
| Q1 2025 | -7.59% |
| Q4 2024 | -48.19% |
| Q3 2024 | -21.03% |
| Q2 2024 | 24.90% |
| Q1 2024 | 5.67% |
| Q4 2023 | -39.46% |
| Q3 2023 | 9.80% |
| Q2 2023 | -28.20% |
| Q1 2023 | 18.60% |
| Q4 2022 | -29.02% |
| Q3 2022 | -2.77% |
| Q2 2022 | 32.60% |
| Q1 2022 | 6.88% |
| Q4 2021 | 24.03% |
| Q3 2021 | -231.23% |
| Q2 2021 | 15.05% |
| Q1 2021 | -32.67% |
| Q4 2020 | -67933.30% |
| Q3 2020 | -128.44% |
| Q2 2020 | 98.51% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |